
<!-- README.md is generated from README.Rmd. Please edit that file -->

# doseresponsemodels <img src="man/figures/logo.png" align="right" width="120"/>

This package provides function to evaluate the Dose-Response models from
the the manuscript **“Updated parameters for the dose-response model for
*Listeria monocytogenes* considering pathogen virulence and age and sex
of consumer”**. from Régis Pouillot, Andreas Kiermeier, Laurent
Guillier, Vasco Cadavez, and Moez Sanaa. *Foods* **2024**, *13*(5), 751
(<https://doi.org/10.3390/foods13050751>).

## R package for Dose Response models

### Package installation

``` r
install.packages("devtools")
devtools::install_github("WorldHealthOrganization/doseresponsemodels")
```

### Usage

The `doseresponsemodels::DRQuick()` function provides a “quick” version
of the function to derive the marginal (over individuals and servings)
probability of invasive listeriosis in a given population for a given
dose in CFU (actual dose if the argument `Poisson = FALSE` or average
dose if the argument `Poisson = TRUE`) using the “JEMRA” 2004, the
“Pouillot” *et al.*, 2015, the “Fritsch” *et al.* 2018, the “EFSA”, 2018
dose-response models or the model developed within this project
(“EFSAMV” for more virulent strains, “EFSAV” for virulent strains, or
“EFSALV” for the less virulent strains).

``` r
library("doseresponsemodels")
help('DRQuick')
DRQuick(1:10,  model="JEMRA", population = 1:2)
DRQuick(1:10,  model="Pouillot", population = 1:11)
DRQuick(1:10,  model="EFSA", population = 1:14)
DRQuick(1:10,  model="EFSAMV", population = 1:14)
```

This function uses (for all model but `JEMRA`) a linear approximation
(`approxfun`) from the exact `doseresponsemodels::DR()` function.

| Model                    | Population | Characteristics              |
|--------------------------|------------|------------------------------|
| JEMRA                    | 0          | Marginal over subpopulations |
| JEMRA                    | 1          | Healthy population           |
| JEMRA                    | 2          | Increased susceptibility     |
| Pouillot                 | 0          | Marginal over subpopulations |
| Pouillot                 | 1          | Less than 65 years old       |
| Pouillot                 | 2          | More than 65 years old       |
| Pouillot                 | 3          | Pregnancy                    |
| Pouillot                 | 4          | Nonhematological Cancer      |
| Pouillot                 | 5          | Hematological cancer         |
| Pouillot                 | 6          | Renal or Liver failure       |
| Pouillot                 | 7          | Solid organ transplant       |
| Pouillot                 | 8          | Inflammatory diseases        |
| Pouillot                 | 9          | HIV/AIDS                     |
| Pouillot                 | 10         | Diabetes                     |
| Pouillot                 | 11         | Heart diseases               |
| Fritsch                  | 0          | Marginal over virulence      |
| Fritsch                  | 1          | Highly virulent              |
| Fritsch                  | 2          | Medium virulent              |
| Fritsch                  | 3          | Hypovirulent                 |
| EFSA-EFSALV-EFSAV-EFSAMV | 0          | Marginal over subpopulations |
| EFSA-EFSALV-EFSAV-EFSAMV | 1          | Female 1-4 yo                |
| EFSA-EFSALV-EFSAV-EFSAMV | 2          | Male 1-4 yo                  |
| EFSA-EFSALV-EFSAV-EFSAMV | 3          | Female 5-14 yo               |
| EFSA-EFSALV-EFSAV-EFSAMV | 4          | Male 5-14 yo                 |
| EFSA-EFSALV-EFSAV-EFSAMV | 5          | Female 15-24 yo              |
| EFSA-EFSALV-EFSAV-EFSAMV | 6          | Male 15-24 yo                |
| EFSA-EFSALV-EFSAV-EFSAMV | 7          | Female 25-44 yo              |
| EFSA-EFSALV-EFSAV-EFSAMV | 8          | Male 25-44 yo                |
| EFSA-EFSALV-EFSAV-EFSAMV | 9          | Female 45-64 yo              |
| EFSA-EFSALV-EFSAV-EFSAMV | 10         | Male 45-64 yo                |
| EFSA-EFSALV-EFSAV-EFSAMV | 11         | Female 65-74 yo              |
| EFSA-EFSALV-EFSAV-EFSAMV | 12         | Male 65-74 yo                |
| EFSA-EFSALV-EFSAV-EFSAMV | 13         | Female \>75 yo               |
| EFSA-EFSALV-EFSAV-EFSAMV | 14         | Male \>75 yo                 |

## References

EFSA (2018). “Scientific opinion on the Listeria monocytogenes
contamination of ready-to-eat foods and the risk from human health in
the EU.” EFSA Journal, 16(1), 5134
(<https://doi.org/10.2903/j.efsa.2018.5134>).

FAO-WHO (2004). “Risk assessment of Listeria monocytogenes in
ready-to-eat foods: Technical report.” World Health Organization and
Food and Agriculture Organization of the United Nations
(<https://www.fao.org/3/y5394e/y5394e00.pdf>).

Fritsch L, Guillier L, Augustin J (2018). “Next generation quantitative
microbiological risk assessment: Refinement of the cold smoked
salmon-related listeriosis risk model by integrating genomic data.”
Microbial Risk Analysis, 10, 20–27.
(<https://doi.org/10.1016/j.mran.2018.06.003>).

Pouillot R, Hoelzer K, Chen Y, Dennis SB (2015). “*Listeria
monocytogenes* dose response revisited–incorporating adjustments for
variability in strain virulence and host susceptibility.” Risk Analysis,
35(1), 90–108. (<https://doi.org/10.1111/risa.12235>).
